Dr. Dixon on Belinostat Plus CHOP in Patients with T-Cell Lymphoma

Chris Comishby Chris Comish

In Social Clips.

0
(0)

In this OncLiveTV video, “Graham Dixon, PhD, chief scientific officer, Onxeo, director, R&D, Onxeo, discusses a phase I study investigating the combination of belinostat (Beleodaq) plus CHOP in patients with peripheral T-cell lymphoma.”

Learn more about lymphoma here: http://bit.ly/1UwWKe6

Print Friendly, PDF & EmailPrint This Page

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment